India's top drug maker Ranbaxy Laboratories said on Tuesday its first-quarter net profit nearly tripled on booming exports of generic drugs to the United States.
India's biggest drug maker Ranbaxy Laboratories Ltd has put in its bid to acquire generic business of German pharmaceutical firm Merck.
Sun Pharma's Dilip Shanghvi is India's richest person.
In the day following Russian tennis star Maria Sharapova's admission that she failed a drug test, sponsors Nike, Porsche and Swiss watchmaker Tag Heuer dropped her like a hot potato.
The death of a participant in a clinical trial by a Hyderabad-based contract research firm has refocused attention on the practices followed by an industry which is said to have great promise, because it can earn good dollars by leveraging cheap Indian skills.
Is young India sexually active? Do they favour contraceptives? What are they doing to ensure safe sex?
Netmed plans to procure from drug manufacturers and sell to pharmacies it has tie-ups with, and to spread its network to all tier-II and tier-III cities.
'Where did this fungus suddenly come from and get all over the country?'
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
Torrent to buy Ranbaxy's anti-bacterial generic
Negotiators from were expected to meet in New Delhi on August 28.
Amritsar-born entrepreneur John Nath Kapoor was arrested by the FBI for bribing doctors to over-prescribe a powerful opioid to patients.
From scanning hospital entrants to disinfecting hospital areas and floors, robots are being roped in for tasks considered high-risk, says Peerzada Abrar.
Sun Pharmaceutical Industries Ltd Chairman Dilip Shanghvi said he expects Ranbaxy Laboratories Ltd to become profitable in the short term.
The company sold over 21 crore (210 million) shares in Sun Pharma.
The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.
The company has been developing donor-derived stem cell platforms.
Indian biotech firm Biocon has been featured amongst the top 25 global biotehnology companies according to a report released by Med Ad News.
Mylan had sued the United States Food and Drugs Administration for providing the exclusive right to Ranbaxy, alleging the permission was given on the basis of 'falsified data'.
The S&P BSE Sensex slipped 305 points to end at 25,400 and the Nifty50 dropped 87 points at 7,783.
Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy
Data exclusivity provides protection to the technical data generated by innovator companies to prove the merit of usefulness of their products.
.jpg)
The company had in May announced that the US Food and Drug Administration had issued an import alert on its Waluj facility, which makes injectables and solid dosages.
An Indian-American woman with close ties to disgraced former Illinois Governor Rod Blagojevich has been sentenced to four years of probation and ordered to pay $200,000 in fines and restitution after she pleaded guilty to billing the state for drug tests her firm never performed.
Earning woes drag markets lower; TCS, HUL lead fall.
Patanjali's packet milk to be lower than competitor brands by Rs 2 a litre
FDI in brownfield investment has resulted in acquisition of domestic drug-manufacturing firms by multinational companies.
The pact would entail the Indian company receiving up to $38 million (over Rs 165 crore).
Domestic firms Aurobindo Pharma, Glenmark Pharmaceuticals and Natco Pharma have received US health regulator's approval to market their generic Rizatriptan Benzoate orally disintegrating tablets used for treating migraine in the American market.
Under the current administration, political attitudes toward IP seem to have improved.
Swiss food giant Nestle has acquired CM&D Pharma, a UK-based drug maker that specialises in the development of products tailored for patients with kidney disease, for an undisclosed amount.
The Supreme Court had rejected the company's plea for a patent on cancer drug Glivec in April.
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
The dry-run was being conducted in state capitals in at least three session sites. Some states also included districts that are situated in difficult terrain or have poor logistical support, according to officials.
Sanofi-aventis on Monday said it has extended its $18.5 billion offer for Genzyme for the second time, a move that will give the French drug-maker additional time to reach an agreement with US biotechnology firm.
Business leaders, among others, ask govt to let go of fiscal target, seek stimulus, and direct cash transfer.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances